Ionis Pharmaceuticals Inc
IONS: XNAS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| yJb | LOCK|Sy?p | LOCK|px^^WV$ |
Ionis: FDA Label Expansion of Tryngolza Expands Commercial Opportunity; Shares Undervalued
Ionis received US approval for the label expansion of Tryngolza in adults with severe hypertriglyceridemia (triglyceride levels of 500 mg/dL or higher). Tryngolza had already been approved in the much rarer indication of familial chylomicronemia syndrome. Shares traded up 2% after hours on June 24.
